VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/05/14
Supreme Pharmaceuticals Inc. (the "Company") (CSE:SL)(OTCBB:SPRWF) has granted 12,000,000 incentive stock options to directors, officers and consultants at an exercise price of $0.05 for a term of five years from this day May 5th, 2014.